Clinical manifestations and natural history of Hodgkin's lymphoma

Cancer Journal

Volumn 15, Issue 2, 2009, Pages 124-128

  Connors, Joseph M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hodgkin's lymphoma; Late complication; Late toxicity; Lymphadenopathy; Lymphoma; Paraneoplastic syndrome; Pattern of spread

Indexed keywords

CHLORMETHINE; CYCLOPHOSPHAMIDE;

B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER FATIGUE; CANCER GROWTH; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RELAPSE; CENTRAL PONTINE MYELINOLYSIS; CEREBELLUM DEGENERATION; CLINICAL FEATURE; DENTAL CARIES; DISEASE COURSE; DISEASE SEVERITY; ENCEPHALITIS; FEVER; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HEMOLYTIC ANEMIA; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; INFECTION; INFERTILITY; LYMPH NODE; LYMPHADENOPATHY; MOTOR NEUROPATHY; NEPHROTIC SYNDROME; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PRURITUS; REVIEW; SPINAL CORD DISEASE; T CELL LYMPHOMA; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; HODGKIN DISEASE; HUMANS; LYMPHATIC DISEASES; PARANEOPLASTIC SYNDROMES;

EID: 68049132895     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181a282d8     Document Type: Review

References (57)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008.
2. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971;31:1860-1861.
3. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630-1636. (Pubitemid 19272832)
4. Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol. 2004;22:3046-3052. (Pubitemid 41103716)
5. Bichel J. Is the alcohol-intolerance syndrome in Hodgkin's disease disappearing? Lancet. 1972;1:1069.
6. Levine AM, Thornton P, Forman SJ, et al. Positive Coombs test in Hodgkin's disease: significance and implications. Blood. 1980;55:607-611. (Pubitemid 10138843)
7. Ozdemir F, Yilmaz M, Akdogan R, et al. Hodgkin's disease and autoimmune hemolytic anemia: a case report. Med Princ Pract. 2005;14:205-207. (Pubitemid 40663302)
8. Hammack J, Kotanides H, Rosenblum MK, et al. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology. 1992;42:1938-1943.
9. Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol. 1995;37(suppl 1):S102-S113.
10. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126:1409-1418.
11. Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet. 1982;1:844-845.
12. Dansey RD, Hammond-Tooke GD, Lai K, et al. Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's disease. Med Pediatr Oncol. 1988;16:284-286. (Pubitemid 18242244)
13. Schold SC, Cho ES, Somasundaram M, et al. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol. 1979;5:271-287. (Pubitemid 9135415)
14. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med. 1994;87:526-530. (Pubitemid 24285563)
15. Chintagumpala MM, Mahoney DH Jr, McClain K, et al. Hodgkin's disease associated with central pontine myelinolysis. Med Pediatr Oncol. 1993;21:311-314. (Pubitemid 23117162)
16. Epaulard O, Courby S, Pavese P, et al. Paraneoplastic acute diffuse encephalitis revealing Hodgkin's disease. Leuk Lymphoma. 2004;45:2509-2512. (Pubitemid 40081199)
17. Bergmann J, Buchheidt D, Waldherr R, et al. IgA nephropathy and hodgkin's disease: a rare coincidence. Case report and literature review. Am J Kidney Dis. 2005;45:e16-e19. (Pubitemid 40038037)
18. Dabbs DJ, Striker LM, Mignon F, et al. Glomerular lesions in lymphomas and leukemias. Am J Med. 1986;80:63-70.
19. Fer MF, McKinney TD, Richardson RL, et al. Cancer and the kidney: complications of neoplasms. Am J Med. 1981;71:704-718.
20. Ma KW, Golbus SM, Kaufman R, et al. Glomerulonephritis with Hodgkin's disease and herpes zoster. Arch Pathol Lab Med. 1978;102:527-529. (Pubitemid 9072683)
21. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355-377. (Pubitemid 29300560)
22. Yum MN, Edwards JL, Kleit S. Glomerular lesions in Hodgkin disease. Arch Pathol. 1975;99:645-649.
23. Shapiro CM, Vander Laan BF, Jao W, et al. Nephrotic syndrome in two patients with cured Hodgkin's disease. Cancer. 1985;55:1799-1804. (Pubitemid 15103929)
24. Delmez JA, Safdar SH, Kissane JM. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. Am J Kidney Dis. 1994;23:743-746.
25. Korzets Z, Golan E, Manor Y, et al. Spontaneously remitting minimal change nephropathy preceding a relapse of Hodgkin's disease by 19 months. Clin Nephrol. 1992;38:125-127.
26. Bierman PJ, Cavalli F, Armitage J. Unusual syndromes in Hodgkin lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, et al, eds. Hodgkin Lymphoma. Philadelphia: Wolters Kluwer; 2007:411-418.
27. Berenguer J, Miralles P, Ribera JM, et al. Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47:422-428.
28. Tanaka PY, Pessoa VP Jr, Pracchia LF, et al. Hodgkin lymphoma among patients infected with HIV in post-HAART era. Clin Lymphoma Myeloma. 2007;7:364-368.
29. Hentrich M, Maretta L, Chow KU, et al. Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Ann Oncol. 2006;17:914-919. (Pubitemid 43778980)
30. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791.
31. Vilchez RA, Finch CJ, Jorgensen JL, et al. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era. Medicine (Baltimore). 2003;82:77-81. (Pubitemid 36331638)
32. Re A, Casari S, Cattaneo C, et al. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer. 2001;92:2739-2745. (Pubitemid 33091909)
33. Powles T, Bower M. HIV-associated Hodgkin's disease. Int J STD AIDS. 2000;11:492-494.
34. Xicoy B, Ribera JM, Miralles P, et al. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma. Haematologica. 2007;92:191-198. (Pubitemid 46860198)
35. Thompson LD, Fisher SI, Chu WS, et al. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol. 2004;121:727-738. (Pubitemid 38534005)
36. Klimm B, Eich HT, Haverkamp H, et al. Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. Ann Oncol. 2007;18:357-363. (Pubitemid 46323106)
37. Klimm B, Diehl V, Engert A. Hodgkin's lymphoma in the elderly: a different disease in patients over 60. Oncology. (Williston Park) 2007;21:982-990; discussion 990, 996, 998 passim.
38. Feltl D, Vitek P, Zamecnik J. Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up. Leuk Lymphoma. 2006;47:1518-1522. (Pubitemid 44364016)
39. Engert A, Ballova V, Haverkamp H, et al. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group. J Clin Oncol. 2005;23:5052-5060. (Pubitemid 46224012)
40. Landgren O, Algernon C, Axdorph U, et al. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica. 2003;88:438-444. (Pubitemid 36547130)
41. Kim HK, Silver B, Li S, et al. Hodgkin's disease in elderly patients (> or = 60): clinical outcome and treatment strategies. Int J Radiat Oncol Biol Phys. 2003;56:556-560. (Pubitemid 36542916)
42. Stark GL, Wood KM, Jack F, et al. Hodgkin's disease in the elderly: a population-based study. Br J Haematol. 2002;119:432-440. (Pubitemid 35365495)
43. Proctor SJ, Rueffer JU, Angus B, et al. Hodgkin's disease in the elderly: current status and future directions. Ann Oncol. 2002;13:133-137. (Pubitemid 34567417)
44. Nogova L, Reineke T, Brillant C, et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol. 2008;26:434-439. (Pubitemid 351171696)
45. Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 2000;96:1889-1899. (Pubitemid 30661074)
46. Diehl V, Franklin J, Sextro M, et al. Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease. In: Armitage JO, Diehl V, Hoppe RT, et al, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams & Wilkins; 1999:563-582.
47. Bodis S, Kraus MD, Pinkus G, et al. Clinical presentation and outcome in lymphocyte predominant Hodgkin's disease. J Clin Oncol. 1997;15:3060-3066. (Pubitemid 27377497)
48. Huang JZ, Weisenburger DD, Vose JM, et al. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma. 2004;45:1551-1557.
49. Osborne BM, Butler JJ. Clinical implications of progressive transformation of germinal centers. Am J Surg Pathol. 1984;8:725-733.
50. Poppema S, Kaiserling E, Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres - a cytohistological study. Histopathology. 1979;3:295-308. (Pubitemid 10232144)
51. Bodis S, Henry-Amar M, Bosq J, et al. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. J Clin Oncol. 1993;11:225-232. (Pubitemid 23046811)
52. Connors JM. Hodgkin's lymphoma: the hazards of success. J Clin Oncol. 2003;21:3388-3390.
53. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431-3439. (Pubitemid 46603515)
54. Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin Oncol. 1990;17:758-768.
55. Henry-Amar M, Hayat M, Meerwaldt JH, et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int J Radiat Oncol Biol Phys. 1990;19:1155-1157.
56. van Leeuwen FE, Swerdlow SH, Travis LB. Second cancers after treatment of Hodgkin lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, et al, eds. Hodgkin Lymphoma. Philadelphia: Wolters Kluwer; 2007:347-370.
57. Vose JM, Constine LS, Sutcliffe SB. Other complications of the treatment of Hodgkin lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, et al, eds. Hodgkin Lymphoma. Philadelphia: Wolters Kluwer; 2007:383-392.